Tokyo Olympics 2020: Coronavirus vaccine not a requirement to hold event, says Games CEO

Toshiro Muto was speaking after a task force meeting with government officials, disease experts and Japanese Olympic officials. It’s the first of several high-level meetings dealing with the COVID-19 pandemic as Tokyo tries to figure out if it can hold the games.

The Associated Press September 04, 2020 18:26:45 IST
Tokyo Olympics 2020: Coronavirus vaccine not a requirement to hold event, says Games CEO

A photographer takes pictures of the illuminated Olympic rings in front of the Rainbow Bridge Friday, Jan. 24, 2020, in the Odaiba district of Tokyo. Tokyo put on a flashy fireworks display on Friday to mark the 6-months-to-go milestone for this summer's Olympics. (AP Photo/Jae C. Hong)

Tokyo: A vaccine is not a requirement for holding next year's postponed Olympics and Paralympics, the CEO of the Tokyo Games said on Friday.

Toshiro Muto was speaking after a task force meeting with government officials, disease experts and Japanese Olympic officials. It’s the first of several high-level meetings dealing with the COVID-19 pandemic as Tokyo tries to figure out if it can hold the games.

“It's not a prerequisite,” Muto said of the vaccine. “The International Olympic Committee and the WHO already discussed this matter. It’s not a condition for the delivery of the Tokyo 2020 Games. A vaccine is not a requirement. Of course, if vaccines are developed we’ll really appreciate it. And for Tokyo 2020 this will be great. But if you ask me if that’s a condition — it's not a condition.”

The task force meetings over the next several months will deal with issues like getting athletes into Japan, COVID-19 testing, measures to keep venues safe, anti-virus measures at the Athletes' Village, immigration issues and the status of fans.

A statement outlining the schedule of five meetings said an “interim summary is planned by approximately the end of 2020.”

“As far a spectators, we don't have any conditions yet, but we'd like to avoid no spectators," Muto said.

Japan is facing a major challenge, with the public skeptical the Olympics can take place — or should take place. Japan has already invested billions, and the delay is likely to cost billions more.

A poll in August of almost 13,000 Japanese companies showed 53.6 percent want the games canceled or postponed again. The IOC has said if the Olympics can’t happen in 2021, they will be cancelled.

A poll in July found that two-thirds of the public also favors another postponement or cancellation.

“While living with the coronavirus, we need to make sure that athletes can perform at their best and audiences enjoy the games safely,” deputy chief cabinet secretary Kasuhiro Sugita said at the meeting. “To achieve that, we will adjust border controls, testing and medical systems and the operations of the venues."

Japan has reported about 1,300 deaths from COVID-19 but new cases in Tokyo have fallen in the last few weeks. The challenge will be bringing in athletes representing 206 nations and territories where COVID-19 conditions are vastly different.

Updated Date:

also read

What is camel flu, a virus deadlier than COVID, that could strike Qatar amid FIFA World Cup 2022?
Health

What is camel flu, a virus deadlier than COVID, that could strike Qatar amid FIFA World Cup 2022?

As 1.2 million football enthusiasts gather in Qatar for the FIFA World Cup 2022, the WHO has warned of a possible outbreak of camel flu, also known as the Middle East Respiratory System (MERS). Considered to be a deadlier cousin of COVID-19, it kills up to a third of those who get infected

'Covid was man-made virus', claims former Wuhan Lab Scientist in his new book 'The Truth About Wuhan'
World

'Covid was man-made virus', claims former Wuhan Lab Scientist in his new book 'The Truth About Wuhan'

Huff reportedly alleges in his book that China's gain-of-function experiments were carried out with insufficient security, leading to a leak at the Wuhan lab

Bharat Biotech’s Intranasal COVID-19 vaccine gets CDSCO approval
Health

Bharat Biotech’s Intranasal COVID-19 vaccine gets CDSCO approval

iNCOVACC is the world’s first Intranasal vaccine for COVID to receive approval for the primary 2-dose schedule, and heterologous booster dose